Immix Biopharma Ownership 2024 | Who Owns Immix Biopharma Now?
Institutional Ownership
7.85%
Insider Ownership
40.18%
Retail Ownership
51.97%
Institutional Holders
9.00
Immix Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AIGH CAPITAL MANAGEMENT LLC | 6.00% | 0.87% | 1,406,680 | -148,320 | -9.54% | 2,785,226 | Jun 30, 2024 |
BLEICHROEDER LP | 3.63% | 0.50% | 850,000 | - | - | 1,683,000 | Jun 30, 2024 |
CABLE CAR CAPITAL LLC | 3.40% | 1.66% | 796,100 | 125,642 | 18.74% | 1,576,278 | Jun 30, 2024 |
VANGUARD GROUP INC | 2.55% | - | 598,537 | 142,351 | 31.20% | 1,185,103 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.66% | 0.00% | 154,685 | -110,815 | -41.74% | 306,276 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.61% | - | 142,128 | 17,358 | 13.91% | 281,454 | Jun 30, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.28% | 0.00% | 65,175 | -33,600 | -34.02% | 129,047 | Jun 30, 2024 |
MORGAN STANLEY | 0.25% | - | 58,457 | 4,412 | 8.16% | 115,745 | Jun 30, 2024 |
STATE STREET CORP | 0.18% | - | 42,960 | - | - | 85,061,000 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.17% | - | 38,914 | - | - | 77,050,000 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.16% | 0.00% | 37,800 | - | - | 74,844 | Jun 30, 2024 |
FNY INVESTMENT ADVISERS, LLC | 0.14% | 0.04% | 32,500 | 7,000 | 27.45% | 64,000 | Jun 30, 2024 |
INVST, LLC | 0.12% | 0.01% | 27,000 | 27,000 | 100.00% | 57,240 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.11% | - | 26,300 | -27,981 | -51.55% | 52,074 | Jun 30, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.11% | 0.00% | 26,080 | - | - | 52,000 | Jun 30, 2024 |
TRITONPOINT WEALTH, LLC | 0.10% | 0.00% | 24,526 | - | - | 48,561 | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.10% | 0.00% | 23,010 | 23,010 | 100.00% | 45,560 | Jun 30, 2024 |
XTX TOPCO LTD | 0.08% | 0.00% | 17,663 | -34,534 | -66.16% | 34,973 | Jun 30, 2024 |
CORSAIR CAPITAL MANAGEMENT, L.P. | 0.06% | 0.00% | 14,217 | -55,168 | -79.51% | 28,150 | Jun 30, 2024 |
BLACKROCK INC. | 0.06% | - | 13,455 | -5,866 | -30.36% | 26,641 | Jun 30, 2024 |
Immix Biopharma's largest institutional shareholder is AIGH CAPITAL MANAGEMENT LLC, holding 6.00% of the company's total share outstanding, currently valued at $2.79M. The top 10 institutional shareholders own together 17.72% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
CABLE CAR CAPITAL LLC | 3.40% | 1.66% | 796,100 | 125,642 | 18.74% | 1,576,278 | Jun 30, 2024 |
AIGH CAPITAL MANAGEMENT LLC | 6.00% | 0.87% | 1,406,680 | -148,320 | -9.54% | 2,785,226 | Jun 30, 2024 |
BLEICHROEDER LP | 3.63% | 0.50% | 850,000 | - | - | 1,683,000 | Jun 30, 2024 |
FNY INVESTMENT ADVISERS, LLC | 0.14% | 0.04% | 32,500 | 7,000 | 27.45% | 64,000 | Jun 30, 2024 |
INVST, LLC | 0.12% | 0.01% | 27,000 | 27,000 | 100.00% | 57,240 | Jun 30, 2024 |
TRITONPOINT WEALTH, LLC | 0.10% | 0.00% | 24,526 | - | - | 48,561 | Jun 30, 2024 |
CORSAIR CAPITAL MANAGEMENT, L.P. | 0.06% | 0.00% | 14,217 | -55,168 | -79.51% | 28,150 | Jun 30, 2024 |
XTX TOPCO LTD | 0.08% | 0.00% | 17,663 | -34,534 | -66.16% | 34,973 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.16% | 0.00% | 37,800 | - | - | 74,844 | Jun 30, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.28% | 0.00% | 65,175 | -33,600 | -34.02% | 129,047 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.66% | 0.00% | 154,685 | -110,815 | -41.74% | 306,276 | Jun 30, 2024 |
OLD NATIONAL BANCORP /IN/ | 0.04% | 0.00% | 10,000 | - | - | 19,800 | Jun 30, 2024 |
TORTOISE INVESTMENT MANAGEMENT, LLC | 0.01% | 0.00% | 1,300 | - | - | 2,574 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 3,986 | -1,710 | -30.02% | 7,893 | Jun 30, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.11% | 0.00% | 26,080 | - | - | 52,000 | Jun 30, 2024 |
COLONY GROUP, LLC | 0.05% | 0.00% | 11,900 | 11,900 | 100.00% | 24,000 | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.10% | 0.00% | 23,010 | 23,010 | 100.00% | 45,560 | Jun 30, 2024 |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 1,492 | - | - | 2,954 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.61% | - | 142,128 | 17,358 | 13.91% | 281,454 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.11% | - | 26,300 | -27,981 | -51.55% | 52,074 | Jun 30, 2024 |
The largest Immix Biopharma shareholder by % of total assets is CABLE CAR CAPITAL LLC. The company owns 796.10K shares of Immix Biopharma (IMMX), representing 1.66% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | 2.55% | - | 598,537 | 142,351 | 31.20% | 1,185,103 | Jun 30, 2024 |
CABLE CAR CAPITAL LLC | 3.40% | 1.66% | 796,100 | 125,642 | 18.74% | 1,576,278 | Jun 30, 2024 |
INVST, LLC | 0.12% | 0.01% | 27,000 | 27,000 | 100.00% | 57,240 | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.10% | 0.00% | 23,010 | 23,010 | 100.00% | 45,560 | Jun 30, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.61% | - | 142,128 | 17,358 | 13.91% | 281,454 | Jun 30, 2024 |
COLONY GROUP, LLC | 0.05% | 0.00% | 11,900 | 11,900 | 100.00% | 24,000 | Jun 30, 2024 |
FNY INVESTMENT ADVISERS, LLC | 0.14% | 0.04% | 32,500 | 7,000 | 27.45% | 64,000 | Jun 30, 2024 |
MORGAN STANLEY | 0.25% | - | 58,457 | 4,412 | 8.16% | 115,745 | Jun 30, 2024 |
ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 950 | 950 | 100.00% | 1,881 | Jun 30, 2024 |
BANK OF AMERICA CORP /DE/ | 0.00% | - | 115 | 115 | 100.00% | 228 | Jun 30, 2024 |
STATE STREET CORP | 0.18% | - | 42,960 | - | - | 85,061,000 | Jun 30, 2024 |
NORTHERN TRUST CORP | 0.17% | - | 38,914 | - | - | 77,050,000 | Jun 30, 2024 |
STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.01% | - | 1,492 | - | - | 2,954 | Jun 30, 2024 |
COMMONWEALTH EQUITY SERVICES, LLC | 0.11% | 0.00% | 26,080 | - | - | 52,000 | Jun 30, 2024 |
TORTOISE INVESTMENT MANAGEMENT, LLC | 0.01% | 0.00% | 1,300 | - | - | 2,574 | Jun 30, 2024 |
OLD NATIONAL BANCORP /IN/ | 0.04% | 0.00% | 10,000 | - | - | 19,800 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.16% | 0.00% | 37,800 | - | - | 74,844 | Jun 30, 2024 |
TRITONPOINT WEALTH, LLC | 0.10% | 0.00% | 24,526 | - | - | 48,561 | Jun 30, 2024 |
BLEICHROEDER LP | 3.63% | 0.50% | 850,000 | - | - | 1,683,000 | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 330 | -104 | -23.96% | 653 | Jun 30, 2024 |
As of Jun 30 2024, Immix Biopharma's largest institutional buyer is VANGUARD GROUP INC. The company purchased 142.35K stocks of IMMX, valued at $1.19M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AIGH CAPITAL MANAGEMENT LLC | 6.00% | 0.87% | 1,406,680 | -148,320 | -9.54% | 2,785,226 | Jun 30, 2024 |
RENAISSANCE TECHNOLOGIES LLC | 0.66% | 0.00% | 154,685 | -110,815 | -41.74% | 306,276 | Jun 30, 2024 |
CORSAIR CAPITAL MANAGEMENT, L.P. | 0.06% | 0.00% | 14,217 | -55,168 | -79.51% | 28,150 | Jun 30, 2024 |
XTX TOPCO LTD | 0.08% | 0.00% | 17,663 | -34,534 | -66.16% | 34,973 | Jun 30, 2024 |
PRIVATE ADVISOR GROUP, LLC | 0.28% | 0.00% | 65,175 | -33,600 | -34.02% | 129,047 | Jun 30, 2024 |
MILLENNIUM MANAGEMENT LLC | 0.11% | - | 26,300 | -27,981 | -51.55% | 52,074 | Jun 30, 2024 |
DIMENSIONAL FUND ADVISORS LP | - | - | - | -24,528 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,862 | -100.00% | - | Jun 30, 2024 |
WALLEYE CAPITAL LLC | - | - | - | -21,926 | -100.00% | - | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | - | -9,039 | -100.00% | - | Jun 30, 2024 |
BLACKROCK INC. | 0.06% | - | 13,455 | -5,866 | -30.36% | 26,641 | Jun 30, 2024 |
UBS GROUP AG | 0.01% | - | 3,154 | -2,104 | -40.02% | 6,245 | Jun 30, 2024 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.02% | 0.00% | 3,986 | -1,710 | -30.02% | 7,893 | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -1,243 | -100.00% | - | Jun 30, 2024 |
SIMPLEX TRADING, LLC | - | - | - | -509 | -100.00% | - | Jun 30, 2024 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 330 | -104 | -23.96% | 653 | Jun 30, 2024 |
BLEICHROEDER LP | 3.63% | 0.50% | 850,000 | - | - | 1,683,000 | Jun 30, 2024 |
TRITONPOINT WEALTH, LLC | 0.10% | 0.00% | 24,526 | - | - | 48,561 | Jun 30, 2024 |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.16% | 0.00% | 37,800 | - | - | 74,844 | Jun 30, 2024 |
OLD NATIONAL BANCORP /IN/ | 0.04% | 0.00% | 10,000 | - | - | 19,800 | Jun 30, 2024 |
As of Jun 30 2024, Immix Biopharma's biggest institutional seller is AIGH CAPITAL MANAGEMENT LLC. The company sold -0.15M shares of IMMX, valued at $2.79M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
INVST, LLC | 0.12% | 0.01% | 27,000 | 27,000 | 100.00% | 57,240 | Jun 30, 2024 |
SQUAREPOINT OPS LLC | 0.10% | 0.00% | 23,010 | 23,010 | 100.00% | 45,560 | Jun 30, 2024 |
COLONY GROUP, LLC | 0.05% | 0.00% | 11,900 | 11,900 | 100.00% | 24,000 | Jun 30, 2024 |
Immix Biopharma's largest new institutional shareholder by number of shares is INVST, LLC, purchased 27.00K shares, valued at $57.24K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
DIMENSIONAL FUND ADVISORS LP | - | - | - | -24,528 | -100.00% | - | Jun 30, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -22,862 | -100.00% | - | Jun 30, 2024 |
WALLEYE CAPITAL LLC | - | - | - | -21,926 | -100.00% | - | Jun 30, 2024 |
JPMORGAN CHASE & CO | - | - | - | -9,039 | -100.00% | - | Jun 30, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -1,243 | -100.00% | - | Jun 30, 2024 |
SIMPLEX TRADING, LLC | - | - | - | -509 | -100.00% | - | Jun 30, 2024 |
Immix Biopharma's largest sold out institutional shareholder by shares sold is DIMENSIONAL FUND ADVISORS LP, sold -24.53K shares, valued at -, as of undefined.
Immix Biopharma Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
360 Funds | 0.14% | 30,000 | 30,000 | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 449,796 | 181,979 | 67.95% | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 81,664 | 3,774 | 4.85% | Feb 29, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 23,822 | 11,911 | 100.00% | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 16,137 | -424 | -2.56% | Mar 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 1,151 | - | - | Mar 31, 2024 |
Immix Biopharma's largest mutual fund holder by % of total assets is "360 Funds", owning 30.00K shares, compromising 0.14% of its total assets.
Immix Biopharma Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 9 | -73.53% |
31 Mar, 24 | 34 | 30.77% |
31 Dec, 23 | 26 | 73.33% |
30 Sep, 23 | 15 | -11.76% |
30 Jun, 23 | 17 | 41.67% |
31 Mar, 23 | 12 | -33.33% |
31 Dec, 22 | 18 | 157.14% |
30 Sep, 22 | 7 | 16.67% |
30 Jun, 22 | 6 | -14.29% |
31 Mar, 22 | 7 | -36.36% |
31 Dec, 21 | 11 | - |
As of 30 Jun 24, 9 institutions are holding Immix Biopharma's shares, representing a decrease of -73.53% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 1,840,040 | -63.85% |
31 Mar, 24 | 5,090,000 | 575.54% |
31 Dec, 23 | 753,468 | 100.29% |
30 Sep, 23 | 376,196 | -40.60% |
30 Jun, 23 | 633,274 | 58.00% |
31 Mar, 23 | 400,796 | -9.07% |
31 Dec, 22 | 440,750 | 47.43% |
30 Sep, 22 | 298,959 | 63.02% |
30 Jun, 22 | 183,385 | 25.19% |
31 Mar, 22 | 146,485 | -90.48% |
31 Dec, 21 | 1,538,439 | - |
Immix Biopharma (IMMX) has 1.84M shares outstanding as of 30 Jun 24, down -63.85% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 7.85% | 1.20% |
31 Mar, 24 | 25.55% | 155.33% |
31 Dec, 23 | 4.06% | 64.81% |
30 Sep, 23 | 2.50% | 12.05% |
30 Jun, 23 | 4.56% | 54.79% |
31 Mar, 23 | 2.88% | 28.63% |
31 Dec, 22 | 3.17% | 68.86% |
30 Sep, 22 | 2.15% | 123.01% |
30 Jun, 22 | 1.32% | 117.76% |
31 Mar, 22 | 1.06% | 0.26% |
31 Dec, 21 | 20.31% | - |
As of 30 Jun 24, Immix Biopharma is held by 7.85% institutional shareholders, representing a 1.20% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 2 | -92.86% |
31 Mar, 24 | 28 | 47.37% |
31 Dec, 23 | 19 | 90.00% |
30 Sep, 23 | 10 | 11.11% |
30 Jun, 23 | 9 | 28.57% |
31 Mar, 23 | 7 | -46.15% |
31 Dec, 22 | 13 | 116.67% |
30 Sep, 22 | 6 | 50.00% |
30 Jun, 22 | 4 | -33.33% |
31 Mar, 22 | 6 | -45.45% |
31 Dec, 21 | 11 | - |
2 institutional shareholders have increased their position in IMMX stock as of 30 Jun 24 compared to 28 in the previous quarter (a -92.86% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 3 | 50.00% |
31 Mar, 24 | 2 | - |
31 Dec, 23 | 2 | - |
30 Sep, 23 | - | -100.00% |
30 Jun, 23 | 4 | 300.00% |
31 Mar, 23 | 1 | -50.00% |
31 Dec, 22 | 2 | - |
30 Sep, 22 | - | - |
30 Jun, 22 | - | -100.00% |
31 Mar, 22 | 1 | - |
31 Dec, 21 | - | - |
3 institutional shareholders have reduced their position in IMMX stock as of 30 Jun 24 compared to 2 in the previous quarter (a 50.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 9 | -73.53% | 1,840,040 | -63.85% | 7.85% | 1.20% | 2 | -92.86% | 3 | 50.00% |
31 Mar, 24 | 34 | 30.77% | 5,090,000 | 575.54% | 25.55% | 155.33% | 28 | 47.37% | 2 | - |
31 Dec, 23 | 26 | 73.33% | 753,468 | 100.29% | 4.06% | 64.81% | 19 | 90.00% | 2 | - |
30 Sep, 23 | 15 | -11.76% | 376,196 | -40.60% | 2.50% | 12.05% | 10 | 11.11% | - | -100.00% |
30 Jun, 23 | 17 | 41.67% | 633,274 | 58.00% | 4.56% | 54.79% | 9 | 28.57% | 4 | 300.00% |
31 Mar, 23 | 12 | -33.33% | 400,796 | -9.07% | 2.88% | 28.63% | 7 | -46.15% | 1 | -50.00% |
31 Dec, 22 | 18 | 157.14% | 440,750 | 47.43% | 3.17% | 68.86% | 13 | 116.67% | 2 | - |
30 Sep, 22 | 7 | 16.67% | 298,959 | 63.02% | 2.15% | 123.01% | 6 | 50.00% | - | - |
30 Jun, 22 | 6 | -14.29% | 183,385 | 25.19% | 1.32% | 117.76% | 4 | -33.33% | - | -100.00% |
31 Mar, 22 | 7 | -36.36% | 146,485 | -90.48% | 1.06% | 0.26% | 6 | -45.45% | 1 | - |
31 Dec, 21 | 11 | - | 1,538,439 | - | 20.31% | - | 11 | - | - | - |
Immix Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
The last insider buy of IMMX was made by Hsu Jason on Jul 31 2024, buying 6,000 shares at $2.15 per share (worth $12.88K).
Immix Biopharma Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 20 | - | - |
Q4 2023 | 2 | - | - |
Q3 2023 | 22 | - | - |
Q4 2022 | 4 | - | - |
Q3 2022 | 8 | 2 | 400.00% |
Q4 2021 | 11 | 16 | 68.75% |
Q2 2021 | - | - | - |
20 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Immix Biopharma's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 4 | - | - |
Q4 2023 | 2 | - | - |
Q3 2023 | 11 | - | - |
Q4 2022 | 4 | - | - |
Q3 2022 | - | 2 | - |
Q4 2021 | 6 | - | - |
Q2 2021 | - | - | - |
As of Q2 2024, Insider owners conducted 4 open market buy trades and 0 open market sell trades of Immix Biopharma's stocks.
Immix Biopharma Peer Ownership
IMMX Ownership FAQ
Who Owns Immix Biopharma?
Immix Biopharma is owned by institutional shareholders (7.85%), insiders (40.18%), and public (51.97%). The largest institutional shareholder of Immix Biopharma is AIGH CAPITAL MANAGEMENT LLC (6.00% of total shares) and the top mutual fund owner is 360 Funds (0.14% of total shares).
Who are the major institutional shareholders of Immix Biopharma?
Immix Biopharma's major institutional shareholders are AIGH CAPITAL MANAGEMENT LLC, BLEICHROEDER LP, CABLE CAR CAPITAL LLC, VANGUARD GROUP INC, and RENAISSANCE TECHNOLOGIES LLC. The top five shareholders own together 16.24% of the company's share outstanding.
How many Immix Biopharma shareholders are there?
As of Jun 2024, there are 9 institutional shareholders of Immix Biopharma.
What percentage of Immix Biopharma is owned by AIGH CAPITAL MANAGEMENT LLC?
AIGH CAPITAL MANAGEMENT LLC owns 1.41M shares of Immix Biopharma, representing 6.00% of the company's total shares outstanding, valued at $2.79M (as of Jun 2024).
What percentage of Immix Biopharma is owned by BLEICHROEDER LP?
As of Jun 2024, BLEICHROEDER LP holds 850K shares of Immix Biopharma (IMMX), compromising 3.63% of the company, valued at $1.68M.
What percentage of Immix Biopharma is owned by CABLE CAR CAPITAL LLC?
CABLE CAR CAPITAL LLC is the third largest holder of Immix Biopharma. The company owns 796.1K of the company's shares outstanding (worth $1.58M).